A Practice-Based, Clinical Pharmacokinetic Study to Inform Levetiracetam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration (PADRE-01).
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2020
published in
has subject area
- Academic Medical Centers
- Acute Kidney Injury
- Administration, Intravenous
- Administration, Oral
- Aged
- Anticonvulsants
- Area Under Curve
- Continuous Renal Replacement Therapy
- Critical Illness
- Dose-Response Relationship, Drug
- Female
- Glomerular Filtration Rate
- Humans
- Intensive Care Units
- Levetiracetam
- Male
- Middle Aged
- Prospective Studies
- Renal Elimination
- Seizures